Everpar Advisors’s Exact Sciences EXAS Stock Holding History

Everpar Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,397	Closed	-$251K	–	242
2023 Q4	$251K	Buy	+3,397	New	+$223K	0.12%	240

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Everpar Advisors's EXAS Position: Q1 2024 in Review

Everpar Advisors sold out of Exact Sciences (EXAS) in Q1 2024, closing a stake of 3,397 shares — an estimated $251K sold.

Everpar Advisors first reported a position in EXAS in Q4 2023 and held it in 1 quarter. The position peaked at $251K in Q4 2023. 625 funds tracked by Wall St. Rank hold EXAS as of Q1 2024.

Everpar Advisors reported no remaining Exact Sciences position as of Q1 2024 after selling out during the quarter.
Everpar Advisors sold 3,397 Exact Sciences shares in Q1 2024, an estimated $251K.
Everpar Advisors first reported a position in Exact Sciences in Q4 2023 and held it in 1 quarter.
Everpar Advisors's Exact Sciences position peaked at $251K in Q4 2023.
625 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2024.

Based on Everpar Advisors's 13F filing for Q1 2024, filed 22 Apr 2024.